Q2 Solutions Receives 2016 Global Supplier Award from Eli Lilly and Company
MORRISVILLE, N.C--(Business Wire / Korea Newswire)--Q2 Solutions, a global clinical trials laboratory services organization, today announced that the company has received the 2016 Lilly Global Supplier Award. Q2 Solutions was one of 12 companies to receive the award this year, recognizing the company’s ongoing contributions to Lilly’s drug development efforts.
Each year, the Lilly Global Supplier Award recognizes suppliers who have worked collaboratively to deliver a positive and measurable impact on Lilly’s corporate objectives and priorities. Lilly presented the award to Q2 Solutions representatives during a special ceremony in Indianapolis.
“It is a tremendous honor to receive this prestigious recognition from Lilly,” said Costa Panagos, chief executive officer, Q2 Solutions. “To earn this award in our first year as an organization is a testament to our employees’ dedication to scientific excellence and on-time, quality delivery. We are proud to be recognized for our work with Lilly; work that we know will help improve human health through innovation that transforms science and data into actionable medical insights.”
About Q2 Solutions, a Quintiles Quest joint venture
Launched in 2015, Q2 Solutions is a global clinical trials laboratory services organization that helps biopharmaceutical, medical device and diagnostics customers improve human health through innovation that transforms science and data into actionable medical insights. Q2 Solutions is a joint venture formed by Quintiles and Quest Diagnostics, combining the clinical trials laboratory services of each parent organization. To learn more, visit www.q2labsolutions.com.
Click (http://goo.gl/XXiXBC) to subscribe to Mobile Alerts for Quintiles.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160623005091/en/
Quintiles Media Relations
+ 1.919.998.1653 (office) +1.919.457.6347 (mobile)
Quintiles Investor Relations
This is a news release distributed by Korea Newswire on behalf of this company.